Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.